Effects of all-trans-retinoic acid and arsenic trioxide on the hemostatic disturbance associated with acute promyelocytic leukemia

Thrombosis Research

Volumn 102, Issue 3, 2001, Pages 197-204

  Zhao, Weili ^a   Wang, Hongli ^a   Wang, Xuefeng ^a   Wu, Fang ^a   Guo, Weimin ^a   Qu, Bin ^a   Shen, Zhixiang ^a   Wang, Zhenyi ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Acute promyelocytic leukemia; All trans retinoic acid; Arsenic trioxide; Tissue factor

Indexed keywords

ALPHA 2 ANTIPLASMIN; ARSENIC TRIOXIDE; D DIMER; FIBRIN MONOMER; FIBRINOGEN; MESSENGER RNA; PADGEM PROTEIN; PLACENTA PROTEIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR; PROCOAGULANT; PROTEIN C; RETINOIC ACID; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; UROKINASE RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; BLAST CELL; CELL LYSATE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IN VIVO STUDY; MALE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; ARSENICALS; CASE-CONTROL STUDIES; FEMALE; HEMORRHAGE; HEMOSTASIS; HEMOSTATICS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; OXIDES; THROMBOPLASTIN; TRETINOIN;

EID: 0035340405     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00233-X     Document Type: Article

References (20)

1. Warrell RP, de Thé H, Wang ZY, Dego L Acute promyelocytic leukemia. N Engl J Med. 329:1993;177-189.
2. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhao L, Gu LJ, Wang ZY Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 72:1988;567-572.
3. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood. 89:1997;3354-3360.
4. Tallman MS Deciphering the pathogenesis of coagulation dysfunction in leukemia. Leuk Res. 20:1996;13-16.
5. Barbui T, Finazzi G, Falanga A The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia. Blood. 91:1998;3093-3102.
6. Falanga A, Lacoviello L, Evangelista V, Belotti D, Consonni R, D'Orazio A, Robba L, Donati MB, Barbui T Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid. Blood. 86:1995;1072-1084.
7. Potgens AIG, Lubsen NH, Van Altena G Measurement of tissue factor messenger RNA levels in human endothelial cells by a quantitative RT-PCR assay. Thromb Haemostasis. 71:1994;208-217.
8. Mackman N, Morrissey JH, Fowler B, Edgington TS Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. Biochemistry. 28:1989;1755-1762.
9. Stefano VD, Teofili L, Sica S, Mastrangel S, Di Mario A, Rutella S, Salutari P, Rumi C, D'Onofrio G, Leone G Effect of all-trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia. Blood. 86:1995;3535-3541.
10. Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Deguchi H, Mori Y, Kanako T, Deguchi K, Fujii J, Shiku H Increased plasma soluble fibrin monomer levels in patients with disseminated intravascular coagulation. Am J Hematol. 51:1996;255-260.
11. Dunlop LC, Skinner MP, Bendall LJ, Favaloro E, Castaldi PA, Gorman J, Gamble JR, Vadas MA, Berndt ML Characterization of GMP-140 (P-selectin) as a circulating plasma protein. J Exp Med. 175:1992;1147-1150.
12. Broze GJ Tissue factor pathway inhibitor. Thromb Haemostasis. 74:1995;90-93.
13. Exmon CT, Gu JM, Xu J Regulation and functions of the protein C anticoagulant pathway. Haematologica. 84:1999;363-368.
14. Koyama T, Hirosawa S, Kawamata N, Tohda S, Aski N All-trans retinoic acid (ATRA) upregulates thrombomodulin and downregulates tissue factor expression in acute promyelocytic leukemia cells: distinct expression of thrombomodulin and tissue factor in human leukemic cells. Blood. 84:1994;3001-3009.
15. Zhu J, Guo WM, Yao YY, Zhao WL, Pan L, Cai X, Ju B, Sun GL, Wang HL, Chen SJ, Chen GQ, Caen J, Chen Z, Wang ZY Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents. Leukemia. 13:1999;1062-1070.
16. Falanga A, Marchetti M, Giovanelli S, Barbui T All-trans-retinoic acid counteracts endothelial cell procoagulant activity induced by a human promyelocytic leukemia-derived cell line (NB4). Blood. 87:1996;613-617.
17. Chambon P A decade of molecular biology of retinoic acid receptors. FASEB J. 10:1996;940-946.
18. Nelson S, Palomba ML, Thames E, Greer P, McCachren SS, Dittman WA Identification and characterization of a retinoic acid responsive element in the gene for human thrombomodulin. Blood. 82:1993;276a.
19. Lansink M, Kooistra T Stimulation of tissue-type plasminogen activator expression by retinoic acid in human endothelial cells requires retinoic acid receptor β2 induction. Blood. 88:1996;531-541.
20. Chen GQ, Zhu J, Shi XG, Ni JH, Zhong HJ, Si GY, Jin XL, Tang W, Li XS, Xiong SM, Shen ZX, Sun GL, Ma J, Zhang P, Zhang TD, Gazin C, Naoe T, Chen SJ, Wang ZY, Chen Z In vitro studies on cellular and molecular mechanisms of arsenic trioxide in the treatment of acute promyelocytic leukemia: arsenic trioxide induces NB4 cell apoptosis with downregulation of bcl-2 expression and modulation of PML-RARa/PML protein. Blood. 88:1996;1052-1065.